Login Register Cart 0
Generic placeholder image

Current Nanoscience

Editor-in-Chief

ISSN (Print): 1573-4137
ISSN (Online): 1875-6786

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Practicality Assessment of a Frugal Nanoparticle Generator: Opening Doors to Nano Pharmaceuticals for the Researchers and Students of Underprivileged Academic Institutions

Author(s): Swayamprakash Patel*, Ashish Patel, Mruduka Patel, Umang Patel, Mehul Patel and Nilay Solanki

Volume 18, Issue 2, 2022

Published on: 09 March, 2021

Page: [237 - 246] Pages: 10

DOI: 10.2174/1573413717666210309121405

Price: $65

Abstract

Background: Probe sonication and high-speed homogenizer are comparatively costly equipment to fabricate the nanoparticles. Many academic and research institutions cannot afford the procurement and maintenance of such sophisticated equipment. In the present work, a newer idea is conceptualized, which can be adopted by underprivileged research institutions to fabricate solid lipid nanoparticles (SLN) in the absence of sophisticated equipment. The current work describes the pilotlevel trials of this novel approach. This study represents the preliminary proof-of-concept trials for which the Indian patent application (3508/MUM/2015) is filed.

Method: A frugal piece of equipment was made using a 50 ml centrifuge tube with conical bottom and a piezoelectric mist maker or humidifier. SLNs were prepared by combining the quasi-emulsion solvent evaporation approach and ultrasonic vibration approach. A quasi-emulsion was composed by the dropwise mixing of the organic solvent containing drug and lipid with an aqueous solution containing surfactant under continuous ultrasonic vibration in the piezoelectric chamber. The size of the droplets was significantly reduced due to piezoelectric ultrasonic vibration. Under the provision of mild vacuum and heat generated by vibration, the organic solvent was evaporated, which leaves behind a suspension of SLN. In the present work, albendazole was selected as a model drug. Various trials with Compritol 888 ATO® and Precirol ATO 5® as a lipid carrier and Tween 80 and Poloxamer 188 as a surfactant were performed. Zeta potential of SLNs was improved by the addition of polyelectrolytes like K2SO4 and Na4P2O7.

Result and Conclusion: The ratio of drug to lipid was optimized to 1:4 for the most favorable results. SLNs with a minimum Z-average diameter of 98.59 nm, -21 mV zeta potential, and 34.064 % (SD 10.78, n=9) entrapment efficiency were developed using the Precirol ATO 5 ® as a lipid carrier. The proof of concept for this novel approach is established through the development of Albendazole SLNs. This approach must also be evaluated for the development of polymeric nanoparticles and vesicular formulations. The further sophistication of the frugal equipment may allow more control over the quality of SLNs. This approach will enable underprivileged researchers to prepare nanopharmaceuticals. Researchers and students of such institutions can focus on the application of SLN by resolving the constraint of sophisticated equipment with this novel approach. This novel approach should also be tried for polymeric and vesicular nanopharmaceuticals.

Keywords: Frugal Innovation, Nanoparticle, Piezoelectric, Quasi-Emulsion, Albendazole, SLN

« Previous Next »
Graphical Abstract

[1]
Agarwal, V.; Bajpai, M.; Sharma, A. Patented and Approval Scenario of Nanopharmaceuticals with Relevancy to Biomedical Application, Manufacturing Procedure and Safety Aspects. Recent Pat. Drug Deliv. Formul., 2018, 12(1), 40-52.
[http://dx.doi.org/10.2174/1872211312666180105114644] [PMID: 29303083]
[2]
Weissig, V.; Guzman-Villanueva, D. Nanopharmaceuticals (part 2): products in the pipeline. Int. J. Nanomedicine, 2015, 10, 1245-1257.
[http://dx.doi.org/10.2147/IJN.S65526] [PMID: 25709446]
[3]
Farjadian, F.; Ghasemi, A.; Gohari, O.; Roointan, A.; Karimi, M.; Hamblin, M.R. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine (Lond.), 2019, 14(1), 93-126.
[http://dx.doi.org/10.2217/nnm-2018-0120] [PMID: 30451076]
[4]
Ventola, C.L. Progress in Nanomedicine: Approved and Investigational Nanodrugs. P&T, 2017, 42(12), 742-755.
[PMID: 29234213]
[5]
Weissig, V.; Pettinger, T.K.; Murdock, N. Nanopharmaceuticals (part 1): products on the market. Int. J. Nanomedicine, 2014, 9, 4357-4373.
[http://dx.doi.org/10.2147/IJN.S46900] [PMID: 25258527]
[6]
Kalepu, S.; Manthina, M.; Padavala, V. Oral lipid-based drug delivery systems – an overview. Acta Pharm. Sin. B, 2013, 3(6), 361-372.
[http://dx.doi.org/10.1016/j.apsb.2013.10.001]
[7]
Mukherjee, S.; Ray, S.; Thakur, R.S. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J. Pharm. Sci., 2009, 71(4), 349-358.
[http://dx.doi.org/10.4103/0250-474X.57282] [PMID: 20502539]
[8]
Puri, A.; Loomis, K.; Smith, B.; Lee, J.H.; Yavlovich, A.; Heldman, E.; Blumenthal, R. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit. Rev. Ther. Drug Carrier Syst., 2009, 26(6), 523-580.
[http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v26.i6.10] [PMID: 20402623]
[9]
Wang, H.; Li, L.; Ye, J.; Wang, R.; Wang, R.; Hu, J.; Wang, Y.; Dong, W.; Xia, X.; Yang, Y.; Gao, Y.; Gao, L.; Liu, Y. Improving the Oral Bioavailability of an Anti-Glioma Prodrug CAT3 Using Novel Solid Lipid Nanoparticles Containing Oleic Acid-CAT3 Conjugates. Pharmaceutics, 2020, 12(2), 126.
[http://dx.doi.org/10.3390/pharmaceutics12020126] [PMID: 32028734]
[10]
Deshpande, A. Solid Lipid Nanoparticles in Drug Delivery: Opportunities and Challenges.Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices; Mitra, A.K.; Cholkar, K; Mandal, A., Ed.; Elsevier: Boston, 2017, pp. 291-330.
[11]
Verma, S.; Gokhale, R.; Burgess, D.J. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int. J. Pharm., 2009, 380(1-2), 216-222.
[http://dx.doi.org/10.1016/j.ijpharm.2009.07.005] [PMID: 19596059]
[12]
Mohamad, A.T. Nanoparticles: A review on their synthesis, characterization and physicochemical properties for energy technology industry. J. Adv. Res. Fluid Mech. Thermal Sci., 2018, 46(1), 1-10.
[13]
Al-Kassas, R.; Bansal, M.; Shaw, J. Nanosizing techniques for improving bioavailability of drugs. J. Control. Release, 2017, 260, 202-212.
[http://dx.doi.org/10.1016/j.jconrel.2017.06.003] [PMID: 28603030]
[14]
Zhang, X.; Li, L.C.; Mao, S. Nanosuspensions of poorly water soluble drugs prepared by top-down technologies. Curr. Pharm. Des., 2014, 20(3), 388-407.
[http://dx.doi.org/10.2174/13816128113199990401] [PMID: 23651400]
[15]
Jenning, V.; Lippacher, A.; Gohla, S.H. Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization. J. Microencapsul., 2002, 19(1), 1-10.
[http://dx.doi.org/10.1080/713817583] [PMID: 11811751]
[16]
Abdullah, M.I.H.C. Optimization on the Nanoparticles Stability in Liquid Phased Condition by Using Taguchi Analysis. J. Adv. Res. Fluid Mech. Therm. Sci., 2019, 61(1), 140-150.
[17]
Chan, H.K.; Kwok, P.C. Production methods for nanodrug particles using the bottom-up approach. Adv. Drug Deliv. Rev., 2011, 63(6), 406-416.
[http://dx.doi.org/10.1016/j.addr.2011.03.011] [PMID: 21457742]
[18]
Abed, M.S.; Abed, A.S.; Othman, F.M. Green Synthesis of Silver Nanoparticles from Natural Compounds: Glucose; Eugenol and Thymol, 2019.
[19]
Azziz, H.N.; Shareef, A.S.; Hadi, H.S. Experimental Investigation of the Ag-Nano Lubricant Effect on Air Conditioning Performance. Journal of Advanced Research in Fluid Mechanics and Thermal Sciences, 2019, 61, 147-154.
[20]
Sjöström, B.; Bergenståhl, B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int. J. Pharm., 1992, 88(1), 53-62.
[http://dx.doi.org/10.1016/0378-5173(92)90303-J]
[21]
Siekmann, B.; Westesen, K. Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. 1996.
[22]
Gallego-Juarez, J. Piezoelectric ceramics and ultrasonic transducers. J. Phys. E Sci. Instrum., 1989, 22(10), 804.
[http://dx.doi.org/10.1088/0022-3735/22/10/001]
[23]
Staff, R.H.; Landfester, K.; Crespy, D. Recent advances in the emulsion solvent evaporation technique for the preparation of nanoparticles and nanocapsules.Hierarchical Macromolecular Structures: 60 Years after the Staudinger Nobel Prize II; Springer, 2013, pp. 329-344.
[http://dx.doi.org/10.1007/12_2013_233]
[24]
Kim, B.K.; Hwang, S.J.; Park, J.B.; Park, H.J. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J. Microencapsul., 2002, 19(6), 811-822.
[http://dx.doi.org/10.1080/0265204021000022770] [PMID: 12569029]
[25]
Castro, L.S.E.P.W.; Kviecinski, M.R.; Ourique, F.; Parisotto, E.B.; Grinevicius, V.M.; Correia, J.F.; Wilhelm Filho, D.; Pedrosa, R.C. Albendazole as a promising molecule for tumor control. Redox Biol., 2016, 10, 90-99.
[http://dx.doi.org/10.1016/j.redox.2016.09.013] [PMID: 27710854]
[26]
Pourgholami, M.H.; Akhter, J.; Wang, L.; Lu, Y.; Morris, D.L. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Cancer Chemother. Pharmacol., 2005, 55(5), 425-432.
[http://dx.doi.org/10.1007/s00280-004-0927-6] [PMID: 15565325]
[27]
Zhou, F.; Du, J.; Wang, J. Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells. Mol. Cell. Biochem., 2017, 428(1-2), 171-178.
[http://dx.doi.org/10.1007/s11010-016-2927-3] [PMID: 28063005]
[28]
Joseph, E.; Singhvi, G. Multifunctional nanocrystals for cancer therapy: a potential nanocarrier.Nanomaterials for Drug Delivery and Therapy; Grumezescu, A.M., Ed.; William Andrew Publishing, 2019, pp. 91-116.
[http://dx.doi.org/10.1016/B978-0-12-816505-8.00007-2]

Rights & Permissions Print Cite
Article Metrics
24
1
© 2024 Bentham Science Publishers | Privacy Policy